Educate Yourself on GIST Research
Jim Hughes outlines the importance of patients/caregivers researching their cancer in order to best advocate for themselves.
Jim Hughes outlines the importance of patients/caregivers researching their cancer in order to best advocate for themselves.
GDOL Chicago will be held at Northwestern University Feinberg School of Medicine, Lurie Baldwin Auditorium. If you have any questions, please contact Diana Nieves at dnieves@liferaftgroup.org
Dr. Candace Haddox of Dana-Farber Cancer Institute will offer invaluable insights into the world of clinical trials in honor of International Clinical Trials Awareness Day as well as discussing trials with GIST Advocate Kandee Evans
Dr. Herbert Loong will summarize abstracts and presentations that were presented during the American Society of Clinical Oncology (ASCO) which is an important conference in the oncology community where new scientific research updates are shared.
July 13th, GIST Awareness Day, is a time when GIST experts, patients, and caregivers come together to educate the public about this disease and advocate for finding a cure. The Life Raft Group invites [...]
Life Fest 2024 San José will feature scientific presentations highlighting the newest research and the latest GIST treatments and will be on July 19-21, 2024.
Dr. Weiss of Washington University School of Medicine in St. Louis will provide an overview of GIST treatments and side effects as well as home management for each type of symptom.
Dr. Kim of Mount Sinai Medical Center will describe various locoregional therapies and their appropriate uses, as well as the role of locoregional therapies and systemic therapy in treating GIST when it metastasizes in the liver.
GDOL Ohio is being held in-person at The Ohio State University Wexner Medical Center, Biomedical Research Tower (BRT), 460 W 12th Ave, Room 115, Columbus, OH 43210
Join us for a full day GIST Day of Learning event in Calgary, Alberta on Saturday September 28, 2024.
Dr. Suzanne George of the Dana-Farber Cancer Institute will review emerging data from the first-in-human StrateGIST 1 trial of IDRX-42 in patients with advanced GIST.
GDOL Miami is being held virtually with the GIST experts at Sylvester Comprehensive Cancer Center.